Product Information

URELLE TABLET is a brand product labeled by Viatris Specialty LLC, priced at $9.4315 per EA under NDC 00037632190. Its NADAC has been published 97 times since Aug 21, 2024.

Strength

.12; 81; 10.8; 32.4; 40.8 mg/1; mg/1; mg/1; mg/1; mg/1

NDC

00037632190

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/1/2026

Approval Type

Unapproved

On Market Since

1/12/2015

Pharmacological Classes

Oxidation-Reduction Activity
Oxidation-Reduction Agent

Price Statistics

The NADAC for URELLE TABLET has been published 97 times since Aug 21, 2024, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.

Current price$9.4315 per EA
All-time high$9.4315 (Jun 24, 2026)
All-time low$8.5749 (Dec 18, 2024)
52-week high$9.4315
52-week low$8.9824
Median price$9.0036
Average price$9.0194
Largest weekly change+5.0% (Jan 7, 2026)
Weeks tracked97
Tracking sinceAug 21, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+4.8%

3Y

N/A

5Y

N/A

All

+9.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of URELLE TABLET?

The current National Average Drug Acquisition Cost (NADAC) for URELLE TABLET, manufactured by Viatris Specialty LLC, is $9.4315 per EA (NDC 00037632190), effective Jun 24, 2026.

How has the price of URELLE TABLET changed over time?

Over the history we have for it, the NADAC for URELLE TABLET has risen 9.9%. It has been tracked across 97 weekly CMS publications since Aug 21, 2024.

What are the highest and lowest recorded NADAC prices for URELLE TABLET?

Since Aug 21, 2024, the NADAC for URELLE TABLET has ranged from a low of $8.5749 (Dec 18, 2024) to a high of $9.4315 (Jun 24, 2026), with a median of $9.0036 per EA.

Are there cheaper alternatives to URELLE TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of URELLE TABLET, so no direct lower-cost alternative is listed.

Who manufactures URELLE TABLET?

URELLE TABLET (NDC 00037632190) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.